Frazier Life Sciences Management, L.P. Bridge Bio Pharma, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.59 Billion
- Q1 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,800,457 shares of BBIO stock, worth $130 Million. This represents 8.27% of its overall portfolio holdings.
Number of Shares
3,800,457
Previous 3,800,457
-0.0%
Holding current value
$130 Million
Previous $104 Million
25.98%
% of portfolio
8.27%
Previous 6.25%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$755 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$660 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$510 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$426 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$246 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.08B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...